IL6 and migraine disorder: Clinical trials, including those by Mottaghi et al. and Ghorbani et al., reveal that vitamin D supplementation (e.g., 50,000 IU weekly or 2000 IU daily) significantly reduces migraine frequency, severity, and associated inflammatory markers like IL-6 and iNOS [183,184].